According to the Journal of the American Medical Association (JAMA, May 1, 2002, Vol. 287 No. 17, pp.2215-2220,) FDA has approved a total of 548 new chemical entities during 1975-1999; however, of which 10.2% acquired a new black box warning or were withdrawn. Chemical drugs will have to gradually yield more room to those biopharmaceuticals from natural sources in certain areas where chemical drugs have failed to deal with. Demand for cheaper and generic drugs are climbing which is caused by the emergence of alternative therapeutic methods and the cost of pharmaceutical was not down due to regulatory and technology barriers. We promise to bring the total solution package for human being to create an absolute tailored health package and committee to tackle with the challenges of improving quality life for poorly or unmet medical needs underthe current healthcare system.

US OncoTherapy Systems BioMedicine Group looks for two perspectives in nature medicine. Internally, it is the science of human Systems Biology presented by biomedicine. Externally, it is material science presented by biotechnology. Under the term of Life Science, BioMedicine is the core software and BioTechnology is the hardware. Without the success of biomedicine, biotechnology would be useless. Without the biomedicine as a key, the research for life science would be meaningless. US OncoTherapy Systems BioMedicine Group promises to let nature medicine be effective with performing simultaneously of biomedicine and biotechnology to bring our goal of One Stop Multi-Diseases Package Solution to human being. (further details: Shocked Lecture in ShangHai)